|
May 12
|
Aclarion Announces Texas Back Institute as New CLARITY Trial Site
|
|
Apr 29
|
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana
|
|
Apr 23
|
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025
|
|
Apr 21
|
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
|
|
Feb 20
|
Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine Summit
|
|
Feb 20
|
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
|
|
Jan 17
|
Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants
|
|
Jan 15
|
Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants
|
|
Jan 3
|
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
|
|
Sep 27
|
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
|
|
Sep 10
|
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
|
|
Sep 6
|
Aclarion Added to PRISM Emerging Medical Devices Index
|
|
Sep 5
|
Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market
|
|
Jun 26
|
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
|
|
Jun 25
|
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
|
|
Jan 29
|
Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?
|
|
Nov 27
|
Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams
|
|
Nov 8
|
Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption
|
|
Nov 6
|
Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD
|
|
Aug 25
|
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
|